Page last updated: 2024-09-04
agn 190299 and gw 3965
agn 190299 has been researched along with gw 3965 in 1 studies
Compound Research Comparison
| Studies (agn 190299) | Trials (agn 190299) | Recent Studies (post-2010) (agn 190299) | Studies (gw 3965) | Trials (gw 3965) | Recent Studies (post-2010) (gw 3965) |
|---|---|---|---|---|---|
| 6 | 0 | 4 | 235 | 0 | 164 |
Protein Interaction Comparison
| Protein | Taxonomy | agn 190299 (IC50) | gw 3965 (IC50) |
|---|---|---|---|
| Alpha-glucosidase MAL32 | Saccharomyces cerevisiae S288C | 4.8 | |
| Oxysterols receptor LXR-beta | Homo sapiens (human) | 0.47 | |
| Oxysterols receptor LXR-alpha | Homo sapiens (human) | 0.5691 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Ferrara, SJ; Scanlan, TS | 1 |
Other Studies
1 other study(ies) available for agn 190299 and gw 3965
| Article | Year |
|---|---|
A CNS-Targeting Prodrug Strategy for Nuclear Receptor Modulators.
Topics: Amides; Amidohydrolases; Animals; Blood-Brain Barrier; Brain; Diffusion; Mice; Mice, Inbred C57BL; Molecular Targeted Therapy; Prodrugs; Receptors, Cytoplasmic and Nuclear; Tissue Distribution | 2020 |